Analyst firms · Citigroup · WRBY
Citigroup WRBY price target and rating history
Warby Parker Inc. (WRBY) · Health Care
Citigroup rates Warby Parker Inc. (WRBY) Neutral with a $17 price target, as of its latest action on Apr 30, 2025. It has published 4 rating actions on WRBY since October 2021, including 1 upgrade and 2 downgrades. Across 3 firms with a WRBY price target in the last 12 months, the median target is $33.
- Current rating
- Neutral
- Price target
- $17
- Median target, all firms
- $33
- Actions on WRBY
- 4
Citigroup price target on WRBY
Every Citigroup rating on WRBY
- Apr 30, 2025
- Feb 5, 2025
- Mar 1, 2023
- Oct 26, 2021
How other firms rate WRBY
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| BofA Securities | Buy | $33 | Jun 29, 2026 |
| Telsey Advisory Group | Outperform | $33 | May 8, 2026 |
| Citizens JMP | Mkt Outperform | $30 | Dec 10, 2025 |
Questions about Citigroup and WRBY
- What is Citigroup's price target for WRBY?
- Citigroup's latest stated price target for Warby Parker Inc. (WRBY) is $17, from its action on Apr 30, 2025.
- What is Citigroup's rating on WRBY?
- Citigroup rates WRBY Neutral, a neutral rating, as of Apr 30, 2025.
- When did Citigroup last change its view on WRBY?
- On Apr 30, 2025, Citigroup upgrades to Neutral from Sell, price target $17.
- How does Citigroup's WRBY target compare with other analysts?
- Across 3 firms with a WRBY price target in the last 12 months, the median target is $33.
More WRBY rating histories
All Citigroup ratingsWRBY news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.